Volume 24, Issue 1 pp. 203-207
Clinical commentary

Focal status epilepticus may trigger relapse of primary angiitis of the CNS

Antoine Guilmot

Antoine Guilmot

Saint-Luc University Hospital, Department of Neurology, Brussels, Belgium

Search for more papers by this author
Sofia Maldonado Slootjes

Sofia Maldonado Slootjes

Saint-Luc University Hospital, Department of Neurology, Brussels, Belgium

Search for more papers by this author
Thierry Duprez

Thierry Duprez

Saint-Luc University Hospital, Department of Radiology, Brussels, Belgium

Search for more papers by this author
Julie Lelotte

Julie Lelotte

Saint-Luc University Hospital, Department of Pathology, Brussels, Belgium

Search for more papers by this author
Martin Lammens

Martin Lammens

Antwerp University Hospital, Department of Pathology, Antwerp, Belgium

Search for more papers by this author
André Peeters

André Peeters

Saint-Luc University Hospital, Department of Neurology, Brussels, Belgium

Saint-Luc University Hospital, Stroke/Vascular Neurology, Brussels, Belgium

Search for more papers by this author
Susana Ferrao Santos

Corresponding Author

Susana Ferrao Santos

Saint-Luc University Hospital, Department of Neurology, Brussels, Belgium

Saint-Luc University Hospital, Centre for Refractory Epilepsy, Brussels, Belgium

Correspondence: Susana Ferrao Santos Avenue Hippocrate 10, 1200 Brussels, Belgium <[email protected]>Search for more papers by this author
First published: 15 February 2022
Citations: 1

Abstract

The role of neuroinflammation in epileptogenesis is extensively investigated, but short-term effects of seizures on established CNS pathologies are less studied and less predictable. We describe the case of a woman with previous recurrent episodes of focal cerebral haemorrhage of unknown cause who developed a pseudo-tumoural oedema triggered by provoked focal status epilepticus. A brain biopsy revealed that the underlying condition was primary angiitis of the CNS. Ictal-induced blood-brain barrier dysfunction allows the entry of water and inflammatory molecules that, in the context of CNS inflammatory diseases, may trigger a self-reinforcing process. Caution should be observed when tapering antiepileptic drugs in patients with such conditions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.